investordatabase.org

BioMedPartners

biomedvc.com Direct investor

BioMedPartners is a venture capital firm founded in 2002, focusing on early-stage life sciences investments in continental Europe, particularly Switzerland and Germany. It has raised over CHF 350 million across three funds and is now in the harvesting phase, while its successor BiomedVC continues the strategy.

BioMedPartners is a venture capital firm headquartered in Basel, Switzerland, founded in 2002. It invests directly in companies, from seed to Series A, in life Sciences, biotech and therapeutics. CHF 350 Mio. under management, as it reports.

“Finding great science and building promising startups to deliver better medicines for patients.”

BioMedPartners, own website
Layer
Direct investor
Type
Venture capital
Stage
SeedSeries A
Headquarters
Basel, Switzerland
Invests in
continental Europe, DACH region, Switzerland, Germany
Sectors
Life Sciences, biotech, therapeutics
Founded
2002
Assets under management
CHF 350 Mio.

Team, as BioMedPartners publishes it

  • Dr. Aristotelis Nastos Managing Partner
  • Dr. Markus Hosang Managing Partner
  • Dr. Michael Wacker Managing Partner
  • Thomas Möller Managing Partner
  • Dr. Valentin Piëch Managing Partner
  • Stefan Fäs CFO, Partner
  • Dr. Morgan Hunter Investment Manager
  • Dr. Marianna Feretzaki Senior Associate
  • Dr. Claudia Ulbrich Venture Partner

Names and roles exactly as listed on biomedvc.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page BioMedPartners publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

  • https://biomedvc.com/name, is_investor, layer, type, hq_country, hq_city, invests_in_geographies, stage_min, stage_max, sectors, thesis_quote, thesis_quote_page, description, founded, aum, people

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 1192 · added 2026-08-28 · link last verified 2026-09-06 · confidence high

Similar investors

Listed under